$59.1 B

AGN Mkt cap, 11-Jul-2018

Allergan Income Statement

Allergan Balance Sheet


USDFY, 2013FY, 2014


3 b4.9 b

Accounts Receivable

883.3 m914.5 m


285.3 m296 m

Current Assets

5.3 b6.9 b


923.2 m1 b


2.3 b2.4 b

Total Assets

10.6 b12.4 b

Accounts Payable

283.2 m287.4 m

Short-term debt

55.6 m72.1 m

Current Liabilities

1.2 b1.6 b

Long-term debt

2.1 b2.1 b

Total Debt

2.2 b2.2 b

Additional Paid-in Capital

3 b3.4 b

Retained Earnings

4.6 b5.9 b

Total Equity

6.5 b7.8 b

Debt to Equity Ratio

0.3 x0.3 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.6 x1.6 x


USDQ1, 2018

Current Liabilities

5.8 b

Total Equity

72.3 b

Allergan Cash Flow


USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m


(27 m)(44 m)

Accounts Payable

37.4 m1.9 m

Cash From Operating Activities

1.7 b1.9 b

Purchases of PP&E

(171.9 m)(243.9 m)

Cash From Investing Activities

(1.4 b)182.7 m

Cash From Financing Activities

28.2 m(204 m)

Income Taxes Paid

455.3 m487.8 m
Report incorrect company information